Literature DB >> 17724683

Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli.

Amber C Donahue1, David A Fruman.   

Abstract

Phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR), a downstream kinase, are both required for proliferation of splenic B cells. However, the functions of PI3K and mTOR in response to different stimuli and among B cell subsets have not been fully elucidated. We used flow cytometry and magnetic cell sorting to examine the requirement for PI3K and mTOR in responses of splenic B cell subsets to BCR and LPS stimulation. BCR-mediated phosphorylation of Akt and Erk is sensitive to the PI3K catalytic inhibitor wortmannin in both marginal zone (MZ) and follicular (FO) cells. BCR-mediated mTOR activation in both subsets is inhibited by wortmannin, though less strongly in MZ cells. In contrast, LPS-induced mTOR signaling is strikingly resistant to wortmannin in both subsets. Similarly, functional responses to LPS are partially wortmannin resistant yet sensitive to mTOR inhibition by rapamycin. We also observed mitogen-independent mTOR activity that is regulated by nutrient availability, and is significantly elevated in MZ cells relative to FO cells. These data define both similarities and differences in PI3K/mTOR signaling mechanisms in MZ and FO cells, and suggest that mTOR signaling can occur in the absence of PI3K activation to promote B cell responses to LPS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724683     DOI: 10.1002/eji.200737281

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  38 in total

Review 1.  Ras family of small GTPases in immunity and inflammation.

Authors:  Derek S Johnson; Youhai H Chen
Journal:  Curr Opin Pharmacol       Date:  2012-03-07       Impact factor: 5.547

2.  Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.

Authors:  Shuling Zhang; Julie A Readinger; Wendy DuBois; Mirkka Janka-Junttila; Richard Robinson; Margaret Pruitt; Val Bliskovsky; Julie Z Wu; Kaori Sakakibara; Jyoti Patel; Carole A Parent; Lino Tessarollo; Pamela L Schwartzberg; Beverly A Mock
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

3.  mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.

Authors:  Hu Zeng; Sivan Cohen; Cliff Guy; Sharad Shrestha; Geoffrey Neale; Scott A Brown; Caryn Cloer; Rigel J Kishton; Xia Gao; Ben Youngblood; Mytrang Do; Ming O Li; Jason W Locasale; Jeffrey C Rathmell; Hongbo Chi
Journal:  Immunity       Date:  2016-09-13       Impact factor: 31.745

4.  2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.

Authors:  Colin M North; Robert B Crawford; Haitian Lu; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

Review 5.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

6.  A switch from canonical to noncanonical autophagy shapes B cell responses.

Authors:  Nuria Martinez-Martin; Paula Maldonado; Francesca Gasparrini; Bruno Frederico; Shweta Aggarwal; Mauro Gaya; Carlson Tsui; Marianne Burbage; Selina Jessica Keppler; Beatriz Montaner; Harold B J Jefferies; Usha Nair; Yan G Zhao; Marie-Charlotte Domart; Lucy Collinson; Andreas Bruckbauer; Sharon A Tooze; Facundo D Batista
Journal:  Science       Date:  2017-02-10       Impact factor: 47.728

Review 7.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

8.  Foxo1 regulates marginal zone B-cell development.

Authors:  Jing Chen; Jose J Limon; Caroline Blanc; Stanford L Peng; David A Fruman
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

9.  Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Authors:  Almut Meyer-Bahlburg; Ashok D Bandaranayake; Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.

Authors:  Boris Shor; Druie Cavender; Crafford Harris
Journal:  BMC Immunol       Date:  2009-05-20       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.